Ebos Group (Ebos Group) Cash And Cash Equivalents : $245 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Ebos Group Cash And Cash Equivalents?

Ebos Group's quarterly cash and cash equivalents declined from Dec. 2022 ($151.70 Mil) to Jun. 2023 ($141.46 Mil) but then increased from Jun. 2023 ($141.46 Mil) to Dec. 2023 ($244.78 Mil).

Ebos Group's annual cash and cash equivalents increased from Jun. 2021 ($129.02 Mil) to Jun. 2022 ($364.41 Mil) but then declined from Jun. 2022 ($364.41 Mil) to Jun. 2023 ($141.46 Mil).

Ebos Group Cash And Cash Equivalents Historical Data

The historical data trend for Ebos Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Cash And Cash Equivalents Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

115.07

168.92

129.02

364.41

141.46

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															356.18	364.41	151.70	141.46	244.78

Ebos Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Ebos Group (OTCPK:EBOSF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Ebos Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Ebos Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (Ebos Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (OTCPK:EBOSF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany EBO:Australia

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (Ebos Group) Headlines

From GuruFocus

Half Year 2024 EBOS Group Ltd Earnings Call Transcript

By GuruFocus Research • 02-28-2024